Abstract:Background: This study aims to explore the variations of hepatic vascular geometries in patients with clinically significant portal hypertension (CSPH) and investigate the capability of using CT/MRI angiographic imaging-based vascular geometrical model (VGM) to identify CSPH patients. Methods: A total of 64 vascular geometrical parameters were extracted from the portal vein (PV), hepatic vein (HV), aorta and inferior vena cava and then fed into a VGM for identification of CSPH patients. A total of 853 consecutive liver cirrhosis patients from 3 medical centers who underwent contrast-enhanced imaging within 14 days of transjugular catheterization for hepatic venous pressure gradient (HVPG) were included. The VGM model was trained and validated on a CT cohort containing 256 cirrhosis patients and 202 age-matched participants without a history of chronic liver diseases, and tested on both CT and MR cohorts. Findings: Significant reduction of whole vessel volumes were observed in both PV (from 36·90±15·99 to 29·61±11·07 cm3) and HV (from 35·28±21·47 to 22·44±15·65 cm3) when CSPH occurred. Similarly, whole vessel lengths were reduced in CSPH patients in both PV (from 3·00±2·37 to 1·72±1·23 m) and HV (from 1·83±1·48 to 0·91±1·51 m). The number of external associations of vessel parameters (defined as R>0·5) increased when CSPH occurred, which verified the derangement of the vascular system in the liver. The performance of VGM outperformed conventional clinical models significantly in both internal and external validation cohorts. Interpretation: This study developed and validated a contrast-enhanced CT/MRI-based VGM with good diagnostic consistency to the HVPG measurement, which shows good potential for clinical applications.Trial Registration: We conducted this study using the database of a CT cohort (CHESS1701; ClinicalTrials.gov identifier: NCT03138915) between August 2016 and September 2017 and a MR cohort (CHESS1802; ClinicalTrials.gov identifier: NCT03766880) from December 2018 toApril 2019.Funding: This study was funded by the National Natural Science Foundation of China (No. 81971583, No. 62001120), National Key R&D Program of China (No. 2018YFC1312900, No. 2019YFA0709502), Science Fund for Distinguished Young Scholars (No. 20JR10RA713), Shanghai Natural Science Foundation (No. 20ZR1406400), Shanghai Municipal Science and Technology Major Project (No.2017SHZDZX01, No.2018SHZDZX01), Shanghai Municipal Science and Technology (No.17411953600), Shanghai Sailing Program (No. 20YF1402400), ZJLab and Key Laboratory of Computational Neuroscience and BrainInspired Intelligence (Fudan University), Ministry of Education, China.Declaration of Interest: The authors declare no conflict of interest.Ethical Approval: The study was in agreement with the ethical guidelines of the 1975 Declaration ofHelsinki and approved by the Ethics Committee of the Fifth Medical Center at PLAGeneral Hospital. The requirement for informed consent was waived.

Research of Correlation Between Hepatic Perfusion Parameters with MSCT Scans and the Model for End-Stage Liver Disease Scorees in Patients with Cirrhosis

Application Values of Gadolinium-ethoxybenzyl Diethylenetriaminepentaacetic Acid Enhanced Magnetic Resonance Imaging-based Radiomics in the Quantitative Assessment of Liver Reserve Function of Patients with Liver Cirrhosis

Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy

Study on the Correlation Between Ultra-High B Value MR Diffusion Imaging and Aquaporin-4 in A Hepatic Ischemic-Reperfusion Model in Rats

A Cohort Study of Regional Liver Function Assessment Using 99Mtc-Gsa Single-photon Emission Computed Tomography (SPECT)/CT Fusion Imaging in Perihilar Cholangiocarcinoma

Evaluation of Cirrhotic Liver with Perfusion-Weighted Magnetic Resonance Imaging: a Preliminary Experimental Study in Animal Models with Half-Liver Cirrhosis.

A clinical study of relationship between noninvasive quantitative ultrasonographic score and clinical score in hepatic fibrosis patients

Prediction of Post-hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma Based on Radiomics Using Gd-EOB-DTPA-Enhanced MRI: the Liver Failure Model

A Study on the Relationship Between Ultrasonographic Score and Clinical Score (MELD, CPT) in Cirrhosis.

The Evaluation of Hemodynamic in Liver Cirrhosis and the Correlation with CTP Score for Liver Reserve Function by Iodometry Function of Dual-energy CT

Study of microcirculation function status of HCC using 3D-DCE-MRI perfusion Tofts model

Development and Validation of a Hepatic Vascular Geometrical Model for Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

Assessment of Prognosis and Curative Effect in Patients with Chronic Severe Hepatitis Using the Model for End-Stage Liver Disease Scores.

Three-dimensional Quantitative Evaluation of the Regional Functional Reserve in the Cirrhotic Liver Using Multi-Modality Imaging

Multiparametric MRI Combined with Liver Volume for Quantitative Evaluation of Liver Function in Patients with Cirrhosis.

The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

A radiomics model of liver CT to predict risk of hepatic encephalopathy secondary to hepatitis B related cirrhosis

The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis

Evaluation of CT perfusion to liver fibrosis and cirrhosis and the correlation research with serum index

Assessment of Liver Fibrosis in Different Degree: Preliminary Study on Multi-Slice CT Perfusion Imaging

Quantitative Study of Hemodynamics of Spleen on Cirrhosis Patients by Dual-energy CT